MeSH term
Frequency | Condition_Probility | Adult | 11 | 0.0 |
Aged | 8 | 0.0 |
Combined Modality Therapy | 2 | 0.0 |
Female | 11 | 0.0 |
Humans | 30 | 0.0 |
Male | 10 | 0.0 |
Middle Aged | 13 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Adolescent | 5 | 0.0 |
Child | 3 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 6 | 0.0 |
Gene Silencing | 2 | 0.0 |
Nuclear Proteins/*genetics | 6 | 1.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Animals | 4 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
*Cell Cycle Proteins | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Mice | 3 | 0.0 |
Genes, p53/*genetics | 3 | 0.0 |
Karyotyping | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
*Chromosome Deletion | 3 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 7 | 3.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Comparative Study | 4 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
Chromosome Mapping | 4 | 0.0 |
Survival Analysis | 2 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
*Carrier Proteins | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Genes, Tumor Suppressor | 3 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Mutation | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Genes, Tumor Suppressor/*genetics | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
*Genes, p53 | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Genotype | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Brain Neoplasms/*genetics | 2 | 1.0 |
Child, Preschool | 2 | 0.0 |
*DNA Methylation | 5 | 0.0 |
Ependymoma/*genetics | 2 | 18.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
p14ARF Protein/genetics | 2 | 9.0 |
Oligodendroglioma/*genetics | 2 | 20.0 |
DNA/metabolism | 2 | 0.0 |
